Generate a tailored SOP for Dr. Aditya Bardia. Improve your application with a focused, well-structured draft.
Dr. Aditya Bardia is a Professor in the Department of Medicine at UCLA Health, specializing in Hematology/Oncology. He has made significant contributions in the field of translational oncology, focusing on improving clinical outcomes for cancer patients. Dr. Bardia serves as the Director of Translational Research Integration and has been the principal investigator for numerous clinical trials investigating precision therapeutics. He has led the clinical development of novel therapies such as sacituzumab govitecan, which has been approved for patients with metastatic triple-negative breast cancer (TNBC), and elacestrant, an oral selective estrogen receptor degrader for metastatic hormone receptor-positive breast cancer. His research also includes the development of blood-based biomarkers, such as circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA), which are crucial for the identification of novel therapeutic targets and monitoring treatment response. His numerous publications in prominent journals attest to his expertise and impact in the field of oncology research.
Department of Economics admits primarily for the PhD program.